Merial is highlighting the results of an independent study published in July's Journal of Dairy Science which showed that treating acutely lame cows with the non-steroidal anti-inflammatory (NSAID) Ketofen (ketoprofen), alongside therapeutic trimming and the application of a block, resulted in a significantly better recovery rate compared to the other treatment protocols used.
In the study, Evaluation of treatments for claw horn lesions in dairy cows in a randomised controlled trial by Thomas et al1, 56% of the cows in the above treatment group were observed to be sound.
Sioned Timothy, Merial Technical Veterinary Manager (pictured right) said: "The lack of evidence to underpin a standardised approach to treating lameness in cattle has previously been highlighted2.
"This study demonstrates the value of using an NSAID as part of lameness treatment both for its welfare benefits, and also to reduce the impact of lameness on herd productivity through improved recovery rates. It also highlights the importance of implementing herd health protocols that focus on early intervention – identifying cows as soon as they become lame should be a priority for dairy farmers. With lameness cited as having a significant adverse effect on milk yield3 and cull rate in the herd, a proactive approach to lameness control is critical. Farmers should work with their vets and foot trimmers to ensure that when lame cows are identified they are treated in the most effective way.”
Sioned added: "The importance of routine mobility scoring cannot be underestimated. Clinical lameness has been shown to cause a decreased milk yield from up to four months before diagnosis 3, which can translate to a mean reduction of 357 litres per 305 day lactation. Furthermore, the impact on fertility and the long term impact on replacement is also acknowledged, with lame cows less likely to conceive and having an increased risk of conception failing."
References
Eurovet Animal Health has announced that its levothyroxine tablet hypothyroidism treatments, Forthyron 200 and Forthyron 400, are now available in a scored snap-tab format that allows the tablet to be broken easily into four equal pieces.
Eurovet says this represents a significant benefit to practices, as individual patients often require varying doses due to differences in absorption and metabolism, requiring a wide variety of strengths of medication to be kept in stock. The new presentation means that veterinary surgeons can provide the accurate, customized, individualised approach that these patients require and since just two strengths need to be stocked, it is easier to manage the dispensary. This saves the practice time and money.
Forthyron contains levothyroxine, a synthetic product, chemically identical to naturally occurring T4 that, due to its long duration of action, is a commonly used treatment for hypothyroidism in dogs.
For further information telephone 01223 257933 or email office@eurovet-ah.co.uk www.eurovet-ah.co.uk
Intervet/Schering-Plough Animal Health has launched a new cattle and sheep vaccine which it says gives vets an additional opportunity to prescribe the broadest possible protection against clostridial diseases.
Bravoxin 10 is a low dose clostridial vaccine containing antigens for protection against C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
Dosage volumes are 2ml for cattle and 1ml for sheep and the new vaccine can be used in animals from as young as two weeks old if the dam has not been previously vaccinated. A booster dose pre-calving or lambing will also deliver 8-12 weeks passive immunity in calves and lambs (apart from against C.haemolyticum).
Intervet/Schering-Plough Animal Health ruminant veterinary adviser Rosemary Booth MRCVS said: "Clostridial bacteria take the lives of cattle and sheep on a regular basis and are the cause of a significant proportion of the sudden livestock deaths in this country. In 2007, an independent survey of over 500 UK dairy and beef farmers revealed that half the interviewees had experienced calves or adult cattle dying for no apparent reason. The reality is that many of these losses could have been due to clostridial diseases. Farmer respondents valued the livestock loss at anywhere between £505 and £1243 per animal. Even at the lowest stock valuation, preventing the loss through broad-spectrum vaccination would pay for nearly five years of Bravoxin 10 use in a 100 cow herd.
"Now that additional clostridial pathogens such as C. sordellii and C. perfringens A have been recognised by the VLA and SAC as significant causes of deaths on both cattle and sheep farms, it makes sense to widen pathogen cover on some ruminant livestock units. Bravoxin 10 allows practitioners to prescribe the broadest possible disease protection."
The sheep industry already understands the importance of broad-spectrum vaccination against clostridial diseases, but Iain Carrington from Intake Veterinary Services based in Northumberland believes cattle producers should also upgrade their protection.
"There was a time that clostridial disease control in cattle meant vaccinating your youngstock against blackleg at turnout, or discovering dead animals and then reacting with blackleg vaccine," he said. "But over the last few years, I have seen an increased incidence of different clostridial diseases in far from typical circumstances.
"There are also a large number of cattle deaths going undiagnosed and it is likely that many are caused by clostridial species. As a result, we are now advising many of our clients to take a broader-spectrum vaccination approach to ensure adequate protection - not only of the cows themselves - but also their calves through good colostral transfer," he said.
Bravoxin 10 is a prescription-only medicine (POM-V). For further information, contact the Intervet/Schering-Plough Animal Health Veterinary Support Group on 01908 685685.
Latest figures from the Food Standards Agency (FSA) indicate that 22% of sheep and goats (3 million) are not stunned before slaughter1.
This is an increase from 2013 when it was estimated 15% (2 million) of sheep and goats were slaughtered without stunning.
At the same time, in a response to a parliamentary question2 from Kerry McCarthy MP (Bristol East), Defra has admitted that it does not hold data on how much of this non-stunned meat is exported.
The BVA says a recent trade deal with Saudi Arabia could greatly increase the exports of British lamb and other meat, some of which may be from non-stun slaughter. Information on the lamb market also indicates that exports in general (especially to non-EU countries) are on the increase, with total export volumes up 14% in 2017 and non-EU volumes growing to 5,400 tonnes – up two-thirds on the previous year3.
The BVA is calling for the timely provision of information on non-stun exports, firstly to ascertain the extent to which the UK is exporting meat from these sources and secondly to inform potential measures to ensure supply matches rather than exceeds domestic demand.
Other EU countries that allow non-stun slaughter have measures in place to limit the export of non-stun meat to help ensure that meat killed by this method is for the domestic market. For example, Germany requires that abattoirs apply for a licence by defining the number of animals to undergo non-stun slaughter to meet local demand only.
BVA President, John Fishwick, said: "Each year millions of animals in the UK are not stunned before slaughter and BVA will continue to push for an end to non-stun slaughter in the interests of animal welfare. The latest FSA figures suggest that a sizeable proportion of sheep and goats that are slaughtered in the UK are done so without stunning and that this seems to outstrip the requirements of the religious communities who consume meat that has been slaughtered in this way.
"It is difficult to unpick the possible factors that contribute to this mismatch but an essential step to understanding this better would be to provide data on how much, if any, non-stun meat is exported abroad. With Brexit on the horizon and in the light of announcements about export deals with non-EU countries, there is a pressing need for clarity on the quantities and destinations of exports of non-stun meat.
"While not illegal, if meat from non-stun religious slaughter is exported we consider this to be outside the spirit of the legislation which allows non-stun as a derogation from the law to meet the needs of religious communities."
The Disciplinary Committee heard that the offence took place in 2013, when Dr Surdila was not a registered veterinary surgeon.
However she pleaded guilty to the charge in 2019, by which time she was.
Dr Surdila testified that in 2010, she and her family owned a few beehives and applied for EU funding to help expand their operation into a business.
A requirement of the funding was that Dr Surdila and her sister belong to a licensed bee-keeping co-operative.
They joined their local co-operative, and paid a consultant to manage their funding application.
Three years later, their consultant switched Dr Surdila and her sister to a different cooperative, for reasons they did not understand.
After another three years or so, Dr Surdila's family decided to close the business because she was at university and the others had other commitments.
Dr Surdila later moved to the UK and joined a practice in Motherwell, Scotland.
Then, in 2019, when Dr Surdila had been in the UK for four years, it transpired that the second co-operative they had joined was unlicensed and they had therefore not been entitled to received the funds from the EU (which amounted to a few thousand euros), and would be prosecuted by the National Department of Anti-Corruption.
Meanwhile, the consultant they had paid to manage their funding application had died.
Dr Surdila stated that everything she had signed for the unlicensed co-op had been signed in good faith, but she was advised by her lawyer that as she had signed legally binding documents for the funding, and because the consultant had died, her only option was to plead guilty.
She was sentenced to two years imprisonment, suspended for two years, 60 days of community service and was required to pay 19,544.7 Romanian Lei (approximately £3,300) in damages.
Her lawyer advised her to appeal her sentence which was harsh considering the circumstances.
However, the appeal was postponed several times because of Covid-19 and was ultimately unsuccessful.
In concluding whether the conviction rendered Dr Surdila unfit to practise, Mrs Judith Way, chairing the Committee and speaking on its behalf, said: “Dr Surdila’s conviction was of a nature and seriousness that required a finding that she was unfit to practise as a veterinary surgeon on public interest grounds”.
The Committee then turned to sanction and in reaching its decision, Mrs Way said: “This was a serious conviction with a significant sentence, involving an element of bad faith.
"The Committee considered it important to mark this behaviour in some way because Dr Surdila should have been more cognisant of what she was signing.
“The Committee noted that her offending behaviour took place a significantly long time ago, when Dr Surdila was young and inexperienced and before she had qualified as a veterinary surgeon.
"There had never been a risk to animals or the public, she had demonstrated significant insight into her failures and exhibited genuine remorse.
"The Committee was satisfied that it was highly unlikely she would ever commit such an offence again.
“In light of the lack of aggravating factors and the extensive mitigation in this case, the Committee concluded that it was appropriate and proportionate to reprimand Dr Surdila and to warn her of the need to ensure she reads and understands all documents that require her signature.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
This year, 13 veterinary surgeons stood for three available places on Council.
6,583 veterinary surgeons voted, a turnout of 18.6% which was significantly down on previous years (24.5% in 2021, 26.2% in 2020 and 25.5% in 2019).
Sue Paterson led the field with 2,358 votes, Olivia Cook came in second with 1,994 votes and Abbie Calow was close behind with 1,820 votes.
Eleanor Ferguson, RCVS Registrar and Returning Officer for both elections, said: “Many congratulations to all successful candidates, who we look forward to welcoming on to RCVS and VN Councils in July.
"Thank you once again this year to everyone who made the decision to stand in this year’s elections and to those who took the time to vote for their preferred candidates.
"We’re not exactly sure why both elections saw falling turnouts this year, but we do appreciate how extremely busy the professions are at the moment, and that everyone’s time is at a premium.
"As part of our ‘Council culture’ project we are looking at ways of improving all aspects of communicating the work around RCVS Council, VN Council and their committees, including around standing for and voting in elections.”
The full results for the RCVS Council election can be found on the 2022 election page.
Mark Bowen, Associate Professor at The University of Nottingham, has been appointed as President of the British Equine Veterinary Association (BEVA) for 2015/16.
Mark will take over the role from Andrew Harrison at the end of BEVA Congress on 12th September. Vicki Nicholls, Veterinary Assistant at Wright and Morten Vets, Cheshire becomes President Elect.
He said: "BEVA’s strengths lie in its members, who are committed to the welfare of the horse and the advancement of clinical practice. With new benefits for members, a new website, a new role for the BEVA Trust and the highest quality of education, BEVA is now an even more forceful and effective voice for the equine profession, both internally and externally.
"Whilst the profession attempts to shape its future for the next 15 years, we must continue to support the innovative individuals in the profession who look ‘outside the box’ and make sure that the future of our profession, the next generation of veterinary surgeons, does not become restricted by dogma and tradition; that they too can replicate the level of innovation seen in equine practice over the last 50 years.
"It is vital that we continue to strengthen our relationships with the British Horseracing Authority and contribute to the development of a funding body to replace the Horserace Betting Levy Board. Our relationship with the BVA, the regulation of allied professionals, the rescheduling of ketamine, the new EU animal health regulations and EU medicines regulations, even the role of Europe, are key areas where BEVA will make veterinary voices heard for the benefit of equine welfare.
"Lastly, employment and retention of veterinary graduates in the profession is a cause of concern to us all. Over the next year we will enhance the Internship Awareness Programme and provide support and mentoring for the younger members of the profession. BEVA council is full of individuals committed to working on your behalf and I am looking forward to working alongside them all for the benefit of us all."
Fitzpatrick Referrals scooped two awards at last week's Vet Marketing Awards, held at the London Vet Show.
The practice picked up the Training Initiatives Award, in recognition of its CPD, Internship and Residency programmes, the launch of Fitzpatrick Learning Academy and the commitment of Fitzpatrick Referrals to pushing the boundaries to advance the veterinary profession.
Noel Fitzpatrick was also awarded the 2011 Science prize for his dedication and commitment to moving the profession forward through scientific and technological development, his research, philosophy and practice.
Organised by Grove House Publishing, who produce OvertheCounter magazine,Vet Marketing and Farm Business, the Vet Marketing Awards are designed to award best practice companies and individuals who are driving innovation in branding, communications and product development, in a way that promotes health and wellbeing for the good of practice, customer, and animals in their care.
Commenting on the Training Initiatives Award, the judges said: "The mission of Fitzpatrick Referrals is to deliver 'the best level of surgical, medical and compassionate care for small animals,' and they have certainly achieved this since the opening of their state-of-the-art practice in 2008. To offer their unparalleled level of care means a high level of training for their staff, and for vets and trainees from across the country. The judges were impressed that they offer more residencies, internships and fellowships than any other private practice in Europe, their commitment to CPD and the in-depth nature of their entry."
Presenting Noel Fitzpatrick with his Science Award, host of the awards ceremony, Alan Whibley, publisher of Vet Marketing said: "For the judges, this is was by far the winner in this category. Noel Fitzpatrick advances scientific and technological development in the veterinary profession, based on the moral and ethical obligation to adopt these new techniques responsibly. He pushes the boundaries, through technology, and also his support for his fellow veterinarians, through internships, CPD lectures and key note speeches, such as the one earlier today. He promulgates the moral imperative to ensure that whilst the client is fully aware of every procedure possible, that a pet is a member of the family and should be treated as such."
Isle of Wight based veterinary surgeon Dan Forster has had his mobile practice named as the best Business to Consumer Start-up at the inaugural Ready for Business Awards 2013.
Dan launched The Mobile Vet in June 2013, since when he has treated patients from across the Isle of Wight and allowed members of the community who may have been unable to take their pets to the vets for years due to illness or age-related conditions access care for their animals. He says his service has also reactivated many dormant patients who had not visited a vet for many years and had fallen behind with vaccinations, plus those who had decided not to visit because their pets were too nervous or aggressive. Apparently, the service has also gone down well with busy families and households with multiple pets.
The judging panel included David Hitchcock of Barclays, Amanda Hurford from the Department for Business, Innovation and Skills and Titus Sharpe, chief executive of MVF Global and winner of the Sunday Times Tech Track 2013. They selected The Mobile Vet as the winner due to its innovative approach whilst still offering all the traditional veterinary services its customers require. The judges were also impressed by its potential for growth, not just in the South East, but possibly throughout the UK and its drive to continually invest in the latest equipment and create additional job opportunities.
Dan said: "We are truly delighted to have our achievements recognised with such a prestigious accolade so soon after launching The Mobile Vet. The help we received to get started and the on-going support available to us has made it possible to develop our idea into a thriving business operation and we now look forward to pushing ahead with our plans for the future."
Kevin Horne, chairman of the Cavendish Consortium added: "In what was a highly competitive category, The Mobile Vet stood out as offering a very difference proposition to its customers and demonstrated a clear understanding of the needs of its clients. We were impressed by the drive and determination shown by Dan and his colleagues to make what is an extremely novel idea a business reality and wish them, and all the other worthy finalists, well as they strive forward."
CEVA Animal Health has launched Marbokem, a Marbofloxacin-based antimicrobial for the treatment of respiratory disease in cattle which offers the advantages of a one-shot protocol and a shock-resistant vial.
Marbokem is used for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. CEVA says Marbofloxacin's efficacy has been proven in terms of re-treatment rate, success, speed of action and MICs in comparison with many frequently used quinolones and macrolides. (1,2,3,4)
According to CEVA, Marbokem's one shot protocol means it's quick and economical to use, while its presentation in an ergonomic CLAS vial makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. The company says Marbokem is also very competitively priced.
For further product information, please contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
1 Grandemange, E., Fournel, S., Woerhle, F. (2009) Field evaluation of the efficacy of 2 antibiotics in treating bovine respiratory infections. Poster, Journées Nationales des GTV, Nantes, France. 2. Grobbel, M., Lübke-Becker, A., Wieler, L., Froyman R., Friederichs, S., Filios, S. (2007) Comparative quantification of the in-vitro activity of veterinary fluoroquinolones. Veterinary microbiology 124 (73-81). 3. Roy, O., Pillet, F., Heurtin-Vallé, A., Frontczak, N. (2008) Comparative field clinical efficacy of a single intramuscular injection of marbofloxacin in the treatment of bovine respiratory disease. Poster, World Buiatrics Congress, Budapest, Hungary.4. Wu, C. (2004) Determination of minimum inhibitory concentrations of danofloxacin and other commonly used cattle antimicrobial agents against Mycoplasma bovis isolated from cattle with clinical disease. Le médecin vétérinaire du Québec. 34 (1-2).
Vetoquinol is introducing Equistro Kerabol Biotin, a complementary feeding stuff for horses which the company says can help maintain healthy hoof and hair growth when used daily.
Equistro Kerabol Biotin will replace Biometh Z and will be automatically supplied in its place when wholesaler stocks of Biometh Z are exhausted.
Equistro Kerabol Biotin is a complex of D-biotin, methionine and Ipaligo zinc in combination with organic selenium and Ipaligo manganese.
Available as a powder in a 3kg bucket which will last 200 days, Vetoquinol says Equistro Kerabol Biotin offers a cost-effective method of ensuring good quality hoof horn.
For more information about any Equistro product, please call 0800 169197 or speak to your local equine territory manager.
Locum vets can now come and update their VetSurgeon Profile to display their location and a business card on a map of the UK which practices can browse when they need a locum (NB. login required to see the locums on the map).
Clicking on a locum’s flag on the VetSurgeon Locum Map reveals a summary profile and the distance they can travel. There are plans to add more detail in the future.
VetSurgeon.org Editor Arlo Guthrie said: "This is all part of our programme of ongoing development with VetSurgeon Jobs, to make sure it is the ‘go to’ place for anyone looking to hire a veterinary surgeon or find a job.
"Whilst I’m here, I’d like to thank the practices and businesses that have already advertised on VetSurgeon Jobs. Your continued support is what allows us to develop these kinds of new features, all designed to help lower your recruitment costs."
Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.
The 12-month surgical guarantee covers professional fees, including consultations, anaesthesia and surgery, involved in rectifying a complication as long as the patient is in good health and the post-surgery instructions have been followed appropriately.
Clinical Director, Andy Moores, an RCVS-Recognised Specialist in Small Animal Orthopaedics, said: “We can never promise that surgery will be free of complications, but we are confident in our low complication rate.
"We are offering a surgical guarantee to demonstrate this confidence and to provide our clients with the reassurance that we will help them get through any post-surgical complications.”
Andy added: “Along with our highly competitive fixed-price fees we hope this guarantee will give owners financial peace-of-mind when their pet needs orthopaedic treatment at this difficult time.
"We do not know of any other specialist orthopaedic centre in the southeast that offers better value care.”
www.mooresortho.com
For free case advice, email: advice@mooresortho.com
RCVS Council had introduced temporary guidance allowing the remote prescription of drugs for animals not under care back in March, to ensure that animal health and welfare could be maintained during lockdown without risking the health of veterinary teams or their clients.
Since then, the College has twice extended this guidance, because of the ongoing situation.
However the College says it now recognises that many practices are returning more to 'business as usual' and that the guidance and associated flowchart should be updated according.
Consequently, before deciding to prescribe POM-Vs remotely, the updated guidance now requires veterinary surgeons to first consider whether the animal is already under their care; or, if not, whether it is possible to physically examine the animal in order to bring the animal under their care. If the answer to both questions is ‘no’, POM-Vs may still be prescribed remotely providing the guidelines set out in the College’s coronavirus advice hub are adhered to.
Surprisingly, the College says that its surveys of the profession have thus far identified no immediate safety concerns around remote prescribing.
RCVS President Dr Mandisa Greene, who chairs the Taskforce, said: “The reason for maintaining the possibility of remote prescribing without a physical examination was that we recognised that the current situation is unpredictable, and while the ability for the public to visit practices in person has improved over the last few months, we felt that situations might still arise where that would not be possible, and where access to remote prescribing would be necessary. These could include further local lockdowns, ongoing quarantine arrangements, and the remaining fact that some members of both the veterinary team and the public continue to shield.
“It remains our intention that this guidance will continue to be a temporary measure and may be subject to further extensions or updates given the uncertain nature of the Covid-19 pandemic.”
RCVS Council will review the position on 8 October, with any changes being effective by 1 November at the earliest.
Meanwhile, the RCVS review of ‘under care’ and out-of-hours emergency cover has now resumed, starting with a number of virtual focus groups and consultation with stakeholders within the veterinary and veterinary nursing professions.
The findings from these focus group discussions will then inform a wider survey to be sent to all veterinary surgeons and veterinary nurses in early 2021, along with stakeholder organisations and the animal-owning public. Remote prescribing will continue to form a part of this review.
This year the event delivered more than 90 hours of CPD lectures, workshops and practicals across six separate streams, over three days. Over 100 veterinary industry leaders showcased their wares in the commercial exhibition hall and there were a number of social events for delegates.
Delegates awarded the scientific programme an average score of 4.7 out of 5 stars, and 94% of delegates said they will put what they learnt into practice and use it in their day-to-day role. 94% also said Congress was good value for money.
Swissvet, a company which makes power dentistry equipment, won the Veterinary Practice Best New Exhibitor Award. CEO Dr Ruedi Steiger said: We have distributors throughout Europe, but it is the first time Swissvet has exhibited at BEVA. It has been a fantastic experience and I am thrilled to have won this award. I definitely plan to come back next year."
Next year’s BEVA Congress will be held in Birmingham from 9-12 September 2020. For further information visit www.beva.org.uk.
Photo: David Boughey
A quick poll carried out by Michael Woodhouse amongst the members of VetSurgeon suggests that the majority of UK veterinary surgeons do not brush their own dog's teeth.
98 members took part in the survey, as follows:
The webinar was hosted by RCVS Senior Vice-President Dr Melissa Donald, with Standards Committee Chair and Junior Vice-President Linda Belton, Registrar Eleanor Ferguson, and Head of Standards Gemma Kingswell.
The panel gave an overview of the main changes for the guidance, which comes into effect on 1st September, the considerations to take into account when prescribing POM-Vs remotely, the circumstances under which POM-Vs cannot be prescribed remotely, the prescription of antibiotics, antifungals, antiparasitics, and antivirals, and how the guidance will be enforced.
The webinar also dealt with issues raised in a previous webinar, including a query about prescribing under the cascade and an update on the position when prescribing based on cultures and sensitivities.
https://www.youtube.com/watch?v=vSTZKdbVD8g
For further information about the new guidance, including a range of practice-based scenarios and FAQs, visit: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/under-care-new-guidance/
Questions about the under care guidance can be sent to advice@rcvs.org.uk
Led by Aarti Kathrani, a senior lecturer in small animal internal medicine at the Royal Veterinary College, and Jennifer Larsen, Professor of Clinical Nutrition at the University of California School of Veterinary Medicine, the presentation will focus on how veterinary professionals in general practice can manage nutritional recommendations for patients that have two or more health conditions with competing or overlapping nutritional needs.
During the webinar, Aarti and Jennifer will share practical insights into making effective clinical decisions when selecting diets for patients with multiple conditions and reflect on how this can support the management of these cases.
They will explore scenarios where the optimal diet for one condition may not be suitable for a concurrent condition, requiring clinicians to prioritise.
The speakers will also address how nutrition and feeding management can be modified to ensure medication delivery without compromising therapeutic efficacy.
The webinar will also address the issue of pet owners seeking non-veterinary recommendations or relying on internet research for advice (something which apparently 78.6% of pet owners do1).
https://webapp.spotme.com/login/eventspace/CollaborativeCareJuly2023
Reference
The new changes are being introduced in the following phases:
The new Environmental Sustainability Award allows practices to demonstrate that they have embedded environmentally sustainable behaviours and are excelling with their sustainability goals.
The Award includes points for reducing waste, consolidating medicines orders and minimising drug wastage, and calculating the practice’s carbon footprint and setting reduction targets.
The changes and additions to the standards at Core Standards and General Practice level cover the sustainability of a wide range of practice areas, including requiring a sustainability policy, communicating sustainability achievements, and minimising anaesthetic gas usage.
As well as improving environmental sustainability, the new and amended standards also include requirements to help make practices more socially sustainable, through measures including increasing diversity and inclusion.
The PSS has produced a list of resources to support veterinary practices with meeting the new environmental sustainability standards and implementing sustainable practices in general.
Mandisa Greene, Chair of the Practice Standards Group, said: “We want to assure PSS-accredited practices that the new standards won’t mean an overhaul of ways of working or result in expensive investment in resources.
"Instead, the standards explain ways that practices can increase their sustainability by putting in place new measures gradually over the next 12 months, in time for them becoming mandatory.
"As with all standards updates, the PSS team are always available to answer any questions that practices have and anyone who is unsure about how to apply them is encouraged to get in touch with the PSS team.”
During the last Standards Committee meeting, there were also several approved clarifications to the standards in the form of guidance notes and minor changes across a range of accreditation levels.
These include updates to the guidance notes for requirements on sterilisation of dental instruments, environmental swabbing of clinical areas, and anaesthetic monitoring.
The new version of the standards that includes all the latest changes, and a separate document listing all the updates, are available to download here: https://www.rcvs.org.uk/setting-standards/practice-standards-scheme/additional-resources
Any questions from practices about the updates can be sent to the PSS team at pss@rcvs.org.uk
Willows' Head of Imaging Andrew Parry, an RCVS and European Specialist in Diagnostic Imaging (pictured on the left with Clinical Director, Toby Gemmill), said: "There are very few veterinary hospitals anywhere in the country which would have the case-load or the complexity of cases to justify such a sizeable investment. Additionally, this magnet will bring multiple opportunities for clinical research which could ultimately lead to improvements in animal health."
Andrew added: “To my knowledge, we are the only centre in the UK that has fully replaced a high-field magnet MRI with a complete new solution.
"This is very unusual as scanners tend to be upgraded from a high field to higher field, rather than replaced altogether.
"However, our aim wasn’t to purely upgrade the equipment, it was to have access to the best diagnostic imaging equipment available, in order to ensure high quality images are obtained and interpreted, providing the most accurate and rapid diagnosis for our patients. This can make a significant difference to the level of care we are able to provide for pets."
For more information, visit: willows.uk.net
The Health Products Regulatory Authority (HPRA) has also granted a marketing authorisation in exceptional circumstances (Article 25, 26 EU Reg 2019/6) for Bultavo 3 in Ireland.
The company says that so far, more than 40 million doses of Bultavo 3 have been distributed in Europe to help limit the spread of BTV-3.
Boehringer points to a recent field study published by the German reference laboratory Friedrich-Loeffler-Institut (FLI), which showed that vaccination of sheep and cattle with Bultavo 3 induces immunity against the virus1.
According to the study, animals vaccinated with Bultavo 3 consistently showed evidence of a protective antibody response to BTV-3, although animals vaccinated with other BTV-3 vaccines did not1.
Boehringer says it is now compiling the data needed to obtain a full marketing authorisation in accordance with Article 8 of EU Regulation 2019/6.
The company says the new addition leverages a combination of image recognition technology, algorithms, and cloud-based deep learning AI to enable accurate, in-clinic sediment analysis of fresh urine, delivering results within minutes.
The system evaluates red and white blood cells, squamous and other epithelial cells (e.g. urothelial and renal tubular epithelial cells), hyaline and non-hyaline casts, struvite and calcium oxalate dihydrate crystals, and cocci and rod bacteria.
Zoetis says its performance is comparable to that of a clinical pathologist.
Richard Goldstein, DVM, DACVIM, DECVIM-CA, Vice President and Chief Medical Officer, Global Diagnostics Medical Affairs at Zoetis said: “Urinalysis is an essential diagnostic test for veterinary surgeons, and often a good indicator of potential wider issues.
"Having the ability to get these results faster will improve the speed and level of care teams can provide their patients, facilitating efficient medical decision-making and helping to ensure smooth workflows.
The company points out that poisoning cases rise dramatically over Christmas, when food that is poisonous to dogs is more likely to be left out and owners are more relaxed (is that a euphemism, TVM?).
For that reason, the Emedog bumper pack contains 20 x 1ml single use vials - four times more than the regular pack and retails at £251.76 a saving of 10% compared to purchasing four regular packs.
Dosage is one vial injected subcutaneously per 10kg and vials have a three-year unopened shelf life, which should minise wastage.
Will Peel MRCVS, Product Manager at TVM UK said: "The number of poisoned animals seen by vets rises dramatically over the festive season so it’s vital that vets have enough product to see them through this time. The Emedog bumper pack will ensure that they are prepared for Christmas with the resources they need to deal with such cases."
The Emedog bumper pack is available from November 2019 from all veterinary wholesalers.
Sarah is a Professor of Veterinary Surgery at the University of Nottingham’s School of Veterinary Medicine & Science, and leads the Nottingham Equine Colic Project, which works with organisations such as the British Horse Society to raise awareness of the condition.
Sarah's talk, 'Generating an evidence-based educational campaign on colic', will discuss new evidence from the project, and how it led to the REACT colic campaign. She will also be sharing experiences of how the campaign has worked and asking whether we can change people's attitudes and behaviours.
The evening starts at 6.15pm with food and refreshments with Sarah's talk starting at 7pm, after which there will be an update on the College’s latest projects and initiatives. That'll be followed by a question and answer session with senior officers and staff from the RCVS - including RCVS President Dr Niall Connell, and Chair of RCVS Veterinary Nurses (VN) Council Racheal Marshall.
Dr Connell said: "Thank you to Professor Freeman for agreeing to speak about the colic project which, through its Colic Awareness Week, is helping to raise knowledge of the early signs of colic amongst horse owners, allowing them to get their horses treated in good time and saving their lives.
"I also look forward to talking to members of the profession about some of the issues currently on their minds – the evening is very much led by what those who attend want to discuss – from mental health, to our under care review, to the Practice Standards Scheme. Attending the event can also count to up to three hours towards your continuing professional development (CPD) requirement."
The event is open to all members of the practice team including veterinary surgeons, veterinary nurses, practice managers and others. The event is free and places can be booked via the RCVS website at www.rcvs.org.uk/nottingham.
In the afternoon before the event, between 12 noon and 5pm, the College will also be holding a series of free 45-minute Practice Standards Scheme (PSS) surgeries with PSS Lead Assessor Pam Mosedale.
The surgeries are open to both RCVS-accredited practices and those considering joining the Scheme and allows delegates to discuss the assessment process, how to apply for awards, how to meet particular requirements and any other questions they may have about the PSS.
Places at the surgeries are limited and will be allocated on a first-come, first-served basis. They can be booked at: www.rcvs.org.uk/PSSsurgeries